Wells Fargo
NTUS

Wells Fargo’s Natus Medical Inc NTUS Stock Holding History

Wells Fargo’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,566
Closed -$215K – 7921
2022
Q2 		$215K Sell
6,566
-119,011
-95% -$3.76M ﹤0.01% 4239
2022
Q1 		$3.3M Sell
125,577
-8,637
-6% -$211K ﹤0.01% 2829
2021
Q4 		$3.19M Sell
134,214
-1,672,188
-93% -$41.3M ﹤0.01% 3027
2021
Q3 		$45.3M Buy
1,806,402
+114,025
+7% +$2.91M 0.01% 1131
2021
Q2 		$44M Buy
1,692,377
+207,352
+14% +$5.64M 0.01% 1153
2021
Q1 		$38M Buy
1,485,025
+209,492
+16% +$5.37M 0.01% 1211
2020
Q4 		$25.6M Buy
1,275,533
+68,791
+6% +$1.35M 0.01% 1379
2020
Q3 		$20.7M Buy
1,206,742
+153,481
+15% +$2.9M 0.01% 1389
2020
Q2 		$23M Buy
1,053,261
+678,402
+181% +$15.5M 0.01% 1281
2020
Q1 		$8.67M Buy
374,859
+127,619
+52% +$3.71M ﹤0.01% 1781
2019
Q4 		$8.16M Buy
247,240
+19,769
+9% +$634K ﹤0.01% 2138
2019
Q3 		$7.24M Buy
227,471
+4,322
+2% +$126K ﹤0.01% 2207
2019
Q2 		$5.73M Buy
223,149
+66,256
+42% +$1.69M ﹤0.01% 2450
2019
Q1 		$3.98M Buy
156,893
+30,927
+25% +$923K ﹤0.01% 2763
2018
Q4 		$4.29M Sell
125,966
-90,193
-42% -$2.93M ﹤0.01% 2590
2018
Q3 		$7.71M Buy
216,159
+3,407
+2% +$120K ﹤0.01% 2280
2018
Q2 		$7.34M Buy
212,752
+15,208
+8% +$533K ﹤0.01% 2327
2018
Q1 		$6.65M Buy
197,544
+52,010
+36% +$1.65M ﹤0.01% 2382
2017
Q4 		$5.56M Buy
145,534
+45,793
+46% +$1.83M ﹤0.01% 2487
2017
Q3 		$3.74M Buy
99,741
+19,726
+25% +$696K ﹤0.01% 2785
2017
Q2 		$2.98M Sell
80,015
-366
-0.5% -$13.2K ﹤0.01% 2885
2017
Q1 		$3.15M Sell
80,381
-351,051
-81% -$13.2M ﹤0.01% 2794
2016
Q4 		$15M Sell
431,432
-140,050
-25% -$5.5M 0.01% 1562
2016
Q3 		$22.5M Buy
571,482
+53,395
+10% +$2.13M 0.01% 1223
2016
Q2 		$19.6M Buy
518,087
+89,630
+21% +$3M 0.01% 1332
2016
Q1 		$16.5M Buy
428,457
+21,927
+5% +$817K 0.01% 1413
2015
Q4 		$19.5M Buy
406,530
+342,390
+534% +$15.8M 0.01% 1337
2015
Q3 		$2.53M Sell
64,140
-4,559
-7% -$194K ﹤0.01% 2825
2015
Q2 		$2.92M Buy
68,699
+9,636
+16% +$384K ﹤0.01% 2811
2015
Q1 		$2.33M Buy
59,063
+23,578
+66% +$869K ﹤0.01% 2930
2014
Q4 		$1.28M Sell
35,485
-830
-2% -$27.9K ﹤0.01% 3343
2014
Q3 		$1.07M Buy
36,315
+25,123
+224% +$693K ﹤0.01% 3427
2014
Q2 		$281K Sell
11,192
-1,262
-10% -$31.2K ﹤0.01% 4213
2014
Q1 		$322K Buy
12,454
+3,093
+33% +$77.9K ﹤0.01% 4110
2013
Q4 		$211K Sell
9,361
-2,050
-18% -$39.6K ﹤0.01% 4220
2013
Q3 		$161K Sell
11,411
-374,130
-97% -$5M ﹤0.01% 4298
2013
Q2 		$5.26M Buy
+385,541
New +$5.25M ﹤0.01% 2079

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Wells Fargo's NTUS Position: Q3 2022 in Review

Wells Fargo sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 6,566 shares — an estimated $215K sold.

Wells Fargo first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $45.3M in Q3 2021. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Wells Fargo reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Wells Fargo sold 6,566 Natus Medical Inc shares in Q3 2022, an estimated $215K.
  • Wells Fargo first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Wells Fargo's Natus Medical Inc position peaked at $45.3M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Wells Fargo's 13F filing for Q3 2022, filed 14 Nov 2022.